Mesenchymal stem cells (MSCs), or multipotent mesenchymal ... Failure to detect engraftment of transplanted MSCs expressing the marker gene after 12 months suggested a possible immune response ...

Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.

December 2024, immediately following the approval of the world's first mesenchymal stromal cells clinical trial, the U.S. FDA ...

BMP9, a less-studied member of the BMP family, exhibits strong osteogenic effects on mesenchymal stem cells (MSCs ... been shown to activate osteogenic markers such as Runx2 and ALP in MSCs ...

We were the first lupus organization in the U.S. to support stromal cell research. In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over ...

Cells were analysed by flow cytometry using antibodies to mesenchymal stem cell markers CD90, CD73 and CD105, as well as qRT-PCR for stem cell and tenogenic markers. ECM components of the fibroblast ...

The tumors in these mice showed high expression of cancer stem cell markers CD56 and CD20 ... long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer ...

SUGAR LAND, Texas--(BUSINESS WIRE)--FDA has authorized Hope Biosciences’ adipose-derived mesenchymal stem cells (HB-adMSCs) for use in the first pediatric clinical trial, to evaluate if ...

Xintela's interim analysis of data from the knee osteoarthritis clinical study shows safety and positive efficacy results, 18 months after treatment with XSTEM. The results demonstrate statistically s ...